Skip to main content

Advertisement

SpringerLink
Log in

Ghrelin and Obestatin Levels in Rheumatoid Arthritis

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Background: Ghrelin is a powerful, endogenous orexigenic peptide. In addition, ghrelin has anti-inflammatory effects, and it has been reported that ghrelin down-regulates pro-inflammatory cytokines, including interleukin (IL)-1β and tumor necrosis factor (TNF)-α. Obestatin appears to decrease food intake and appetite, and its potential role in inflammation is not yet clear. The aims of this study were to assess total and acylated (active) ghrelin and obestatin serum levels and their relations with inflammatory status in rheumatoid arthritis (RA) patients. Design: Fasting blood samples were obtained from 37 patients with RA, 29 patients with Behçet’s disease (BD) and 28 healthy controls (HC). Total ghrelin and obestatin levels were measured by radioimmunoassay and acylated ghrelin was quantified by enzyme-linked immunosorbent assay. Results: Patients with RA had lower total ghrelin, but higher obestatin levels than patients with BD (p < 0.05 for both), but when compared with HC group differences were not significant. There was no difference across groups in terms of acylated ghrelin. Total ghrelin level was not correlated with any study parameters in the all groups. Obestatin level correlated with erythrocyte sedimentation rate and DAS-28 in the RA group, the level of IL-6 in the BD group, and with the level of TNF-α in the HC group (r = 0.400, p < 0.05; r = 0.412, p < 0.05, r = 0.543, p < 0.01 and r = 0.528, p < 0.05, respectively). Conclusions: Our results did not show a significant correlation between circulating ghrelin and clinical or laboratory markers of disease activity in RA. Surprisingly, obestatin correlated with some inflammatory markers. So, obestatin seems to be more valuable than ghrelin in the pathogenesis of RA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kojima, M., H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa. 1999. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656–659 doi:10.1038/45230.

    Article  PubMed  CAS  Google Scholar 

  2. Hosoda, H., M. Kojima, and K. Kangawa. 2006. Biological, physiological, and pharmacological aspects of ghrelin. J. Pharmacol. Sci. 100:398–410 doi:10.1254/jphs.CRJ06002X.

    Article  PubMed  CAS  Google Scholar 

  3. Leite-Moreira, A. F., and J. B. Soares. 2007. Physiological, pathological and potential therapeutic roles of ghrelin. Drug Discov. Today 12:276–88 doi:10.1016/j.drudis.2007.02.009.

    Article  PubMed  CAS  Google Scholar 

  4. Zhang, J. V., P. G. Ren, O. Avsian-Kretchmer, C. W. Luo, R. Rauch, C. Klein et al. 2005. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin’s effects on food intake. Science 310:996–999 doi:10.1126/science.1117255.

    Article  PubMed  CAS  Google Scholar 

  5. Sibilia, V., E. Bresciani, N. Lattuada, D. Rapetti, V. Locatelli, V. De Luca et al. 2006. Intracerebroventricular acute and chronic administration of obestatin minimally affect food intake but not weight gain in the rat. J. Endocrinol. Invest. 29:RC31–RC34.

    PubMed  CAS  Google Scholar 

  6. Zizzari, P., R. Longchamps, J. Epelbaum, and M. T. Bluet-Pajot. 2007. Obestatin partially affects ghrelin stimulation of food intake and GH secretion in rodents. Endocrinology 148:1648–1653 doi:10.1210/en.2006–1231.

    Article  PubMed  CAS  Google Scholar 

  7. Dixit, V. D., and D. D. Taub. 2005. Ghrelin and immunity: a young player in an old field. Exp. Gerontol. 40:900–910 doi:10.1016/j.exger.2005.09.003.

    Article  PubMed  CAS  Google Scholar 

  8. Dixit, V. D., E. M. Schaffer, R. S. Pyle, S. K. Sakthivel, R. Palaniappan Jr., J. W. Lillard et al. 2004. Ghrelin inhibits leptin—and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest. 114:57–66.

    PubMed  CAS  Google Scholar 

  9. Granado, M., T. Priego, A. I. Martín, M. A. Villanúa, and A. López-Calderón. 2005. Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats. Am. J. Physiol. Endocrinol. Metab. 288:E486–92 doi:10.1152/ajpendo.00196.2004.

    Article  PubMed  CAS  Google Scholar 

  10. Peracchi, M., D. Conte, C. Terrani, S. Pizzinelli, C. Gebbia, V. Cappiello et al. 2003. Circulating ghrelin levels in celiac patients. Am. J. Gastroenterol. 98:2474–2478 doi:10.1111/j.1572–0241.2003.07709.x.

    Article  PubMed  CAS  Google Scholar 

  11. Otero, M., R. Nogueiras, F. Lago, C. Dieguez, J. J. Gomez-Reino, and O. Gualillo. 2004. Chronic inflammation modulates ghrelin levels in humans and rats. Rheumatology (Oxford) 43:306–310 doi:10.1093/rheumatology/keh055.

    Article  CAS  Google Scholar 

  12. Toussirot, E., G. Streit, N. U. Nguyen, G. Dumoulin, G. Le Huédé, P. Saas et al. 2007. Adipose tissue, serum adipokines, and ghrelin in patients with ankylosing spondylitis. Metabolism 56:1383–1989 doi:10.1016/j.metabol.2007.05.009.

    Article  PubMed  CAS  Google Scholar 

  13. Jasin, H. E. 2005. Mechanisms of tissue damage in rheumatoid arthritis. In: Arthritis and allied conditions a textbook of rheumatology, Koopman, and Moreland eds. 15Williams & Wilkins, Philadelphia, pp. 1141–1164.

    Google Scholar 

  14. Sakane, T., M. Takeno, N. Suzuki, and G. Inaba. 1999. Behcet’s disease. N. Engl. J. Med. 341:1284–1291 doi:10.1056/NEJM199910213411707.

    Article  PubMed  CAS  Google Scholar 

  15. Roubenoff, R., R. A. Roubenoff, L. M. Ward, S. M. Holland, and D. B. Hellmann. 1992. Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor. J. Rheumatol. 19:1505–1510.

    PubMed  CAS  Google Scholar 

  16. Walsmith, J., and R. A. Roubenoff. 2002. Cachexia in rheumatoid arthritis. Int. J. Cardiol. 85:89–99 doi:10.1016/S0167-5273(02)00237-1.

    Article  PubMed  Google Scholar 

  17. Arnett, F. C., S. M. Edworthy, D. A. Bloch, D. J. McShane, J. F. Fries, N. S. Cooper et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:315–24 doi:10.1002/art.1780310302.

    Article  PubMed  CAS  Google Scholar 

  18. The International Study Group for Behcet’s disease. 1992. Evaluation of diagnostic (‘classification’) criteria in Behcet’s disease—towards internationally agreed criteria. Br. J. Rheumatol. 31:299–308.

    Article  Google Scholar 

  19. Leeb, B. F., I. Andel, J. Sautner, M. Bogdan, A. Maktari, T. Nothnagl et al. 2005. Disease activity measurement of rheumatoid arthritis: Comparison of the simplified disease activity index (SDAI) and the disease activity score including 28 joints (DAS28) in daily routine. Arthritis Rheum. 53:56–60 doi:10.1002/art.20923.

    Article  PubMed  Google Scholar 

  20. Yazici, C., K. Kose, M. Calis, M. DemIr, M. Kirnap, and F. Ates. 2004. Increased advanced oxidation protein products in Behcet’s disease: a new activity marker? Br. J. Dermatol. 151:105–11 doi:10.1111/j.1365-2133.2004.06003.x.

    Article  PubMed  CAS  Google Scholar 

  21. Bekpinar, S., N. Kilic, Y. Unlucerci, A. Akdag-Kose, G. Azizlerli, and Z. Ozbek-Kir. 2005. Evaluation of nitrosative and oxidative stress in Behcet disease. J. Eur. Acad. Dermatol. Venereol. 19:167–71 doi:10.1111/j.1468-3083.2005.01075.x.

    Article  PubMed  CAS  Google Scholar 

  22. Hosoda, H., and K. Kangawa. 2004. Ghrelin measurement. Nippon Rinsho. 9:354–356.

    Google Scholar 

  23. Li, W. G., D. Gavrila, X. Liu, L. Wang, S. Gunnlaugsson, L. L. Stoll et al. 2004. Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells. Circulation 109:2221–2216 doi:10.1161/01.CIR.0000127956.43874.F2.

    Article  PubMed  CAS  Google Scholar 

  24. Işerim, S. O., G. Sener, B. Saglam, F. Ercan, N. Gedik, and B. C. Yeğen. 2008. Ghrelin alleviates biliary obstruction-induced chronic hepatic injury in rats. Regul Pept. 146:73–79 doi:10.1016/j.regpep.2007.08.014.

    Article  Google Scholar 

  25. Wang, L., N. R. Basa, A. Shaikh, A. Luckey, D. Heber, D. H. St-Pierre et al. 2006. LPS inhibits fasted plasma ghrelin levels in rats: role of IL-1 and PGs and functional implications. Am. J. Physiol. Gastrointest. Live.r Physiol. 291:G611–G620 doi:10.1152/ajpgi.00533.2005.

    Article  CAS  Google Scholar 

  26. Gayle, D. A., M. Desai, E. Casillas, R. Beloosesky, and M. G. Ross. 2006. Gender-specific orexigenic and anorexigenic mechanisms in rats. Life Sci. 79:1531–1536 doi:10.1016/j.lfs.2006.04.015.

    Article  PubMed  CAS  Google Scholar 

  27. Hataya, Y., T. Akamizu, H. Hosoda, N. Kanamoto, K. Moriyama, K. Kangawa et al. 2003. Alterations of plasma ghrelin levels in rats with lipopolysaccharide-induced wasting syndrome and effects of ghrelin treatment on the syndrome. Endocrinology 144:5365–5371 doi:10.1210/en.2003-0427.

    Article  PubMed  CAS  Google Scholar 

  28. Chang, L., J. Zhao, J. Yang, Z. Zhang, J. Du, and C. Tang. 2003. Therapeutic effects of ghrelin on endotoxic shock in rats. Eur J Pharmacol. 473:171–176 doi:10.1016/S0014-2999(03)01972-1.

    Article  PubMed  CAS  Google Scholar 

  29. Kümpers, P., R. Horn, G. Brabant, A. Woywodt, M. Schiffer, H. Haller et al. 2008. Serum leptin and ghrelin correlate with disease activity in ANCA-associated vasculitis. Rheumatology (Oxford) 47:484–487 doi:10.1093/rheumatology/ken023.

    Article  Google Scholar 

  30. Peracchi, M., M. T. Bardella, F. Caprioli, S. Massironi, D. Conte, L. Valenti et al. 2006. Circulating ghrelin levels in patients with inflammatory bowel disease. Gut. 55:432–423 doi:10.1136/gut.2005.079483.

    Article  PubMed  CAS  Google Scholar 

  31. Otto, B., M. Tschöp, W. Heldwein, A. F. Pfeiffer, and S. Diederich. 2004. Endogenous and exogenous glucocorticoids decrease plasma ghrelin in humans. Eur. J. Endocrinol. 151:113–117 doi:10.1530/eje.0.1510113.

    Article  PubMed  CAS  Google Scholar 

  32. Madison, L. D., J. M. Scarlett, P. Levasseur, X. Zhu, K. Newcomb, A. Batra et al. 2008. Prostacyclin signaling regulates circulating ghrelin during acute inflammation. J. Endocrinol. 196:263–273 doi:10.1677/JOE-07-0478.

    Article  PubMed  CAS  Google Scholar 

  33. El Eter, E., A. Al Tuwaijiri, H. Hagar, and M. Arafa. 2007. In vivo and in vitro antioxidant activity of ghrelin: Attenuation of gastric ischemic injury in the rat. J Gastroenterol Hepatol. 22:1791–1799 doi:10.1111/j.1440-1746.2006.04696.x.

    Article  PubMed  Google Scholar 

  34. Isik, A., S. S. Koca, B. Ustundag, H. Celik, and A. Yildirim. 2007. Paraoxonase and arylesterase levels in rheumatoid arthritis. Clin. Rheumatol. 26:342–348 doi:10.1007/s10067-006-0300-8.

    Article  PubMed  CAS  Google Scholar 

  35. Hotta, M., R. Ohwada, H. Katakami, T. Shibasaki, N. Hizuka, and K. Takano. 2004. Plasma levels of intact and degraded ghrelin and their responses to glucose infusion in anorexia nervosa. J. Clin. Endocrino.l Metab. 89:5707–5712 doi:10.1210/jc.2004-0353.

    Article  CAS  Google Scholar 

  36. Gourcerol, G., T. Coskun, L. S. Craft, J. P. Mayer, M. L. Heiman, L. Wang et al. 2007. Preproghrelin-derived peptide, obestatin, fails to influence food intake in lean or obese rodents. Obesity (Silver Spring) 15:2643–52.

    Article  CAS  Google Scholar 

  37. Gourcerol, G., D. H. St-Pierre, and Y. Taché. 2007. Lack of obestatin effects on food intake: should obestatin be renamed ghrelin-associated peptide (GAP)? Regul Pept. 141:1–7 doi:10.1016/j.regpep.2006.12.023.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Rheumatology, Faculty of Medicine, Firat University, Firat Tip Merkezi, Ic Hastaliklari AD./Romatoloji BD., 23119, Elazig, Turkey

    Suleyman Serdar Koca, Metin Ozgen, Sait Dag, Bahri Evren & Ahmet Isik

  2. Department of Biochemistry, Faculty of Medicine, Firat University, Firat Tip Merkezi, Ic Hastaliklari AD./Romatoloji BD., 23119, Elazig, Turkey

    Suleyman Aydin

Authors
  1. Suleyman Serdar Koca
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Metin Ozgen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Suleyman Aydin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sait Dag
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bahri Evren
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ahmet Isik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Suleyman Serdar Koca.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koca, S.S., Ozgen, M., Aydin, S. et al. Ghrelin and Obestatin Levels in Rheumatoid Arthritis. Inflammation 31, 329–335 (2008). https://doi.org/10.1007/s10753-008-9082-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-008-9082-2

KEY WORDS

Search

Navigation